Skip to main content

Back to Cancer Australia's website

Australian Government - Cancer Australia
Home

Search form

EdCaN - learning resources for nurses

  • EdCaN learning resources
  • Professional development
  • About EdCaN
  • Contact us

Search form

  • Alkylating agents
  • Antimetabolites
  • Antitumour antibiotics
  • Plant alkaloids
  • Miscellaneous agents
  • Hormonal agents
  1. EdCaN learning resources
  2. Supporting resources
  3. Antineoplastic agents
  4. Classification
  5. Hormonal agents
  • Printer-friendly version
  • A|A

Hormonal agents

  • Using the EdCaN resources
  • Case-based learning resources
  • Supporting resources
    • The cancer journey
    • Population health concepts
    • The biology of cancer
    • Cancer treatment planning
    • Surgery
    • Radiotherapy
    • Antineoplastic agents
      • Overview
      • Role of antineoplastics
      • Key concepts
      • Classification
      • Selection and administration
      • Administration principles
      • Models of care
      • Responses
      • Toxicity grading scales
      • References
    • Targeted therapies
    • Stem cell transplantation
    • Supportive care
    • Aboriginal and Torres Strait Islander peoples
  • Entry to specialty program
  • Alkylating agents
  • Antimetabolites
  • Antitumour antibiotics
  • Plant alkaloids
  • Miscellaneous agents
  • Hormonal agents

Hormonal agents alter the internal / extracellular environment. Most agents are cell cycle phase non-specific. Breast, thyroid, prostate and uterine cancers are examples of tumours that are sensitive to hormonal manipulation. With these diseases, the action of hormones or hormone antagonists depends on the presence of hormone receptors in the tumours themselves (i.e. oestrogen receptors in breast cancers). 1, 7, 11 There are individual classifications of hormonal agents:13

  • adrenocorticoids, eg. prednisone
  • androgens, eg. testosterone propionate
  • oestrogens, eg. diethylstilbestrol 
  • selective oestrogen receptor modulators, eg. tamoxifen citrate
  • selective aromatase inhibitors, eg. anastrozole 
  • progesterones, eg. megestrol acetate
  • antitestosterone , eg. flutamide 

Major toxicities occur in the gastrointestinal, sexual / reproductive systems and mood and sleep pattern changes.1, 7, 11

Learning activity

Choose one hormonal agent and discuss its:

  • Indications in cancer control.
  • Mechanism of action.
  • Adverse effects.
  • Administration considerations.

Next: Factors influencing agent selection and administration

  • Copyright © 2023 - Cancer Australia
  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy